Paula Rackoff

Summary

Affiliation: Beth Israel Medical Center
Country: USA

Publications

  1. pmc Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
    Paula Rackoff
    Division of Rheumatology, Beth Israel Medical Center, New York, NY 10003, USA
    Clin Interv Aging 4:207-14. 2009

Detail Information

Publications1

  1. pmc Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
    Paula Rackoff
    Division of Rheumatology, Beth Israel Medical Center, New York, NY 10003, USA
    Clin Interv Aging 4:207-14. 2009
    ..The mechanism, efficacy, dosing options, and tolerability of risedronate are reviewed...